Pardi

Pardi v. Tricida, Inc.

Good Law
United States District Court, Northern District of CaliforniaOctober 10, 20244:21-cv-00076California6,638 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 MICHAEL PARDI, et al., Case No. 21-cv-00076-HSG (LJC)

Plaintiffs,

ORDER REGARDING DISCOVERY

v. LETTER BRIEFS

TRICIDA, INC., et al., Re: Dkt. Nos. 166, 185 Defendants.

I. INTRODUCTION This case concerns allegations that misrepresentation by Defendant Gerrit Klaerner regarding FDA review of a pharmaceutical product called veverimer that Tricida, Inc. was developing affected the value of Tricida stock, including stock purchased by Lead Plaintiff Jeffrey Fiore. Klaerner was Tricida’s founder and CEO. Tricida was initially named as a defendant in this case, but Plaintiffs voluntarily dismissed their claims against Tricida when it entered bankruptcy proceedings. Judge Gilliam has referred all discovery disputes to the undersigned magistrate judge, and the parties have filed two joint letters regarding discovery disputes: a letter addressing several requests for production that Fiore served on Klaerner (ECF No. 166), and a …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.